In the pharmaceutical industry, the quest for efficient drug delivery, enhanced solubility, and stabilization of active ingredients is constant. Wacker Chemie AG offers a cutting-edge solution with CAVAMAX® W6 PHARMA, a pharmaceutical-grade alpha-cyclodextrin. This highly specialized excipient, with its unique properties, is designed to meet the complex demands of modern pharmaceutical formulations.
What is CAVAMAX® W6 PHARMA?
CAVAMAX® W6 PHARMA is a form of alpha-cyclodextrin, consisting of six glucose units. It boasts the smallest cavity among the parent cyclodextrins, which makes it exceptionally useful for encapsulating small molecules. This functionality enables it to improve the solubility, stability, and bioavailability of active pharmaceutical ingredients (APIs). Moreover, CAVAMAX® W6 PHARMA is produced with the highest standards of purity and compliance, making it a trusted choice for pharmaceutical and personal care applications worldwide.
Key Properties
CAVAMAX® W6 PHARMA is characterized by its high purity and compliance with pharmaceutical standards. It contains a minimum of 98.0% alpha-cyclodextrin and adheres to the specifications set by the European Pharmacopoeia (Ph. Eur.) and the United States Pharmacopeia-National Formulary (USP/NF). Additionally, it is the only alpha-cyclodextrin of its kind produced by Wacker Chemie AG, ensuring exclusive quality and consistency.
- CAS Number: 10016-20-3
- Molecular Formula: C36H60O30
- Molecular Weight: 972.84 g/mol
- Purity: Minimum 98.0%, compliant with Ph. Eur. and USP/NF monographs.
CAVAMAX® W6 PHARMA also exhibits excellent solubility in water, with a solubility rate of 110.3 g/l at 20°C. Its ability to dissolve easily makes it ideal for formulations requiring rapid release of the active ingredient. Furthermore, it complies with rigorous microbial standards, ensuring the safety and quality of the final pharmaceutical product.
Applications in Pharmaceuticals and Personal Care
One of the standout applications of CAVAMAX® W6 PHARMA is in the solubilization, stabilization, and delivery of small active molecules, such as fatty acids. Its inclusion in pharmaceutical formulations can enhance the bioavailability of orally administered drugs, ensuring that the active ingredients are absorbed more efficiently in the body. Additionally, it serves as a taste-masking agent, which is particularly beneficial for improving patient compliance with bitter or unpleasant-tasting medications.
In the realm of personal care, CAVAMAX® W6 PHARMA contributes to the stabilization and delivery of cosmetic ingredients, ensuring that skincare and haircare products maintain their efficacy over time.
Packaging and Storage
CAVAMAX® W6 PHARMA is available in various packaging options, including 25 kg, 1,000 kg, and bulk quantities. For optimal preservation, it is recommended to store the product in sealed containers at room temperature under dry conditions. The shelf life of CAVAMAX® W6 PHARMA extends up to five years from the date of production when stored properly.
Certifications and Compliance
To meet the diverse needs of global markets, CAVAMAX® W6 PHARMA is certified Kosher and Halal and complies with the FSSC 22000 food safety management standards. Its production follows stringent pharmaceutical guidelines, ensuring it meets the highest quality and safety standards for use in drug formulations.
Conclusion
CAVAMAX® W6 PHARMA represents a significant advancement in pharmaceutical excipients, offering a powerful solution for enhancing drug formulations. Its ability to improve the solubility, stability, and bioavailability of active ingredients makes it an invaluable component in the development of modern medications. Whether for pharmaceuticals or personal care products, CAVAMAX® W6 PHARMA delivers exceptional performance, backed by Wacker Chemie AG's commitment to quality and innovation.
